Your account is not claimed yet. You can sign up with ORCID to claim your account.

Larissa S Carnevalli (Larissa Carnevalli)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

NPJ breast cancer

Nature communications

Journal for immunotherapy of cancer

Oncoimmunology

AstraZeneca R&D Cambridge

Universidade Federal de Sao Paulo Escola Paulista de Medicina (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca R&D Cambridge May 1o 2019

United Kingdom

Team Leader :: Bioscience, Oncology

Education History

Universidade Federal de Sao Paulo Escola Paulista de Medicina

Brazil

PHD :: Microbiology, Immunology and Parasitology

Publications

Lorna Hopcroft, Eleanor M Wigmore, Stuart Charles Williamson, Susana Ros, Cath Eberlein, Jennifer I Moss, Jelena Urosevic, Larissa S Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J A Goodwin, Brandon S Willis, Claire Rooney, Elza C de Bruin, Simon T Barry
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. NPJ breast cancer 9 (1) (2023)
Lorna Hopcroft, Eleanor M Wigmore, Stuart Charles Williamson, Susana Ros, Cath Eberlein, Jennifer I Moss, Jelena Urosevic, Larissa S Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J A Goodwin, Brandon S Willis, Claire Rooney, Elza C de Bruin, Simon T Barry
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. NPJ breast cancer 9 (1) (2023)
Mandy Lawson, Natalie Cureton, Susana Ros, Azadeh Cheraghchi-Bashi-Astaneh, Jelena Urosevic, Sophie D'Arcy, Oona Delpuech, Michelle DuPont, David I Fisher, Eric T Gangl, Hilary J Lewis, Dawn Trueman, Neha Wali, Stuart Charles Williamson, Jennifer I Moss, Elodie Montaudon, Héloïse Derrien, Elisabetta Marangoni, Ricardo J Miragaia, Sladjana Gagrica, Pablo Morentin Gutierrez, Thomas Moss, Gareth A Maglennon, Daniel Sutton, Radoslaw Polanski, Alan Rosen, Jonathan Cairns, Pei Zhang, Mònica Sánchez-Guixé, Violeta Serra, Susan E Critchlow, James S Scott, Justin P O Lindemann, Simon T Barry, Teresa Klinowska, Christopher J Morrow, Larissa S Carnevalli
The next-generation oral selective estrogen receptor degrader camizestrant (AZD9833) suppresses ER+ breast cancer growth and overcomes endocrine and CDK4/6 inhibitor resistance. Cancer research (2023)
Lorna Hopcroft, Eleanor M Wigmore, Stuart Charles Williamson, Susana Ros, Cath Eberlein, Jennifer I Moss, Jelena Urosevic, Larissa S Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffman, Daniel Sutton, Stewart Jones, Richard J A Goodwin, Brandon S Willis, Claire Rooney, Elza C de Bruin, Simon T Barry
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models. NPJ breast cancer 9 (1) (2023)
Elizabeth A Kuczynski, Giulia Morlino, Alison Peter, Anna M L Coenen-Stass, Jennifer I Moss, Neha Wali, Oona Delpuech, Avinash Reddy, Anisha Solanki, Charles Sinclair, Dinis Pedro Calado, Larissa S Carnevalli
A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability. EMBO molecular medicine 14 (6) (2022)
Alison Harrod, Chun-Fui Lai, Isabella Goldsbrough, Georgia M Simmons, Natasha Oppermans, Daniela B Santos, Balazs Győrffy, Rebecca C Allsopp, Bradley J Toghill, Kirsty Balachandran, Mandy Lawson, Christopher J Morrow, Manasa Surakala, Larissa S Carnevalli, Pei Zhang, David S Guttery, Jacqueline A Shaw, R Charles Coombes, Lakjaya Buluwela, Simak Ali
Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer. Oncogene 41 (44) (2022)
Filipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, Carolin Margarethe Sauer, Maria Vias, Mihaela Angelova, Deborah Sanders, Anna Piskorz, James Hall, Karen Hosking, Anumithra Amirthanayagam, Sabina Cosulich, Larissa S Carnevalli, Barry R Davies, Thomas B K Watkins, Ionut-Gabriel Funingana, Helen Bolton, Krishnayan Haldar, John Latimer, Peter Baldwin, Robin Crawford, Matthew D Eldridge, Bristi Basu, Mercedes Jimenez-Linan, Andrew W Mcpherson, Nicholas McGranahan, Kevin Litchfield, Sohrab P Shah, Iain A McNeish, Carlos Caldas, Gerard I Evan, Charles Swanton, James D Brenton
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer. Nature communications 13 (1) (2022)
Alexey S Revenko, Larissa S Carnevalli, Charles Sinclair, Ben Johnson, Alison Peter, Molly Taylor, Lisa Hettrick, Melissa Chapman, Stephanie Klein, Anisha Solanki, Danielle Gattis, Andrew Watt, Adina M Hughes, Lukasz Magiera, Gozde Kar, Lucy Ireland, Deanna A Mele, Vasu Sah, Maneesh Singh, Josephine Walton, Maelle Mairesse, Matthew King, Mark Edbrooke, Paul Lyne, Simon T Barry, Stephen Fawell, Frederick W Goldberg, A Robert MacLeod
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Journal for immunotherapy of cancer 10 (4) (2022)
Dimitra Georgopoulou, Maurizio Callari, Oscar M Rueda, Abigail Shea, Alistair Martin, Agnese Giovannetti, Fatime Qosaj, Ali Dariush, Suet-Feung Chin, Larissa S Carnevalli, Elena Provenzano, Wendy Greenwood, Giulia Lerda, Elham Esmaeilishirazifard, Martin O'Reilly, Violeta Serra, Dario Bressan, null null, Gordon B Mills, H Raza Ali, Sabina S Cosulich, Gregory J Hannon, Alejandra Bruna, Carlos Caldas
Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response. Nature communications 12 (1) (2021)
Larissa S Carnevalli, Molly Ann Taylor, Matthew King, Anna M L Coenen-Stass, Adina M Hughes, Sigourney Bell, Theresa A Proia, Yanjun Wang, Antonio Ramos-Montoya, Neha Wali, Danielle Carroll, Maneesh Singh, Michele Moschetta, Pablo Morentin Gutierrez, Cristina Gardelli, Susan E Critchlow, Teresa Klinowska, Stephen E Fawell, Simon T Barry
Macrophage Activation Status Rather than Repolarization Is Associated with Enhanced Checkpoint Activity in Combination with PI3Kγ Inhibition. Molecular cancer therapeutics 20 (6) (2021)
Graham P Collins, Tracy N Clevenger, Kathleen A Burke, Buyue Yang, Alex MacDonald, David Cunningham, Christopher P Fox, Andre Goy, John Gribben, Grzegorz S Nowakowski, Mark J Roschewski, Julie M Vose, Anusha Vallurupalli, Jean Cheung, Amelia Raymond, Barrett Nuttall, Dan Stetson, Brian A Dougherty, Stein Schalkwijk, Larissa S Carnevalli, Brandon Willis, Lin Tao, Elizabeth A Harrington, Ahmed Hamdy, Raquel Izumi, J Elizabeth Pease, Melanie M Frigault, Ian Flinn
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies. Leukemia & lymphoma 62 (11) (2021)
Silvia Basilico, Xiaonan Wang, Alison Kennedy, Konstantinos Tzelepis, George Giotopoulos, Sarah J Kinston, Pedro M Quiros, Kim Wong, David J Adams, Larissa S Carnevalli, Brian James Patrick Huntly, George S Vassiliou, Fernando J Calero-Nieto, Berthold Göttgens
Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML. Nature communications 11 (1) (2020)
Theresa A Proia, Maneesh Singh, Richard Woessner, Larissa S Carnevalli, Gayathri Bommakanti, Lukasz Magiera, Srimathi Srinivasan, Shaun Grosskurth, Michael P Collins, Chris Womack, Matthew Griffin, Minwei Ye, Susan Cantin, Deanna L Russell, Mingchao Xie, Adina M Hughes, Nanhua Deng, Deanna A Mele, Stephen Fawell, Simon T Barry, Corinne Reimer, J Carl Barrett, Patricia McCoon
STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti-PD-L1. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)
Sophie Langdon, Adina M Hughes, Molly Ann Taylor, Elizabeth A Kuczynski, Deanna A Mele, Oona Delpuech, Laura Jarvis, Anna Staniszewska, Sabina Cosulich, Larissa S Carnevalli, Charles Sinclair
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity. Oncoimmunology 7 (8) (2018)
Larissa S Carnevalli, Charles Sinclair, Molly A Taylor, Pablo Morentin Gutierrez, Sophie Langdon, Anna M L Coenen-Stass, Lorraine Mooney, Adina Hughes, Laura Jarvis, Anna Staniszewska, Claire Crafter, Ben Sidders, Elizabeth Hardaker, Kevin Hudson, Simon T Barry
PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity. Journal for immunotherapy of cancer 6 (1) (2018)

Larissa S Carnevalli.css-eqlu8i{font-size:small;padding-left:4px;} (Larissa Carnevalli)

Publication Activity (10 Years)

Top Topics

Top Venues

Larissa S Carnevalli (Larissa Carnevalli)